Global Heparin API
Market Report
2025
Heparin API market size will be $6,867.66 Million by 2030.Heparin API Industry's Compound Annual Growth Rate will be 4.75% from 2023 to 2030.
The base year for the calculation is 2024. The historical will be 2021 to 2024. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Heparin API Market Report 2025.
As per Cognitive Market Research's latest published report, the Global Heparin API market size will be $6,867.66 Million by 2030.Heparin API Industry's Compound Annual Growth Rate will be 4.75% from 2023 to 2030.
The Unfractionated Heparin segment Revenue will be USD 1,630.51 Million by 2029.
The Animal Sourced Heparin segment Revenue in Heparin API will be USD 6,417.02 Million by 2029.
The Heparin Sodium API segment Revenue in Heparin API will be USD 3,263.73 Million by 2029.
The North America Heparin API market size is will be USD 2,301.47 Million by 2029.
2021 | 2025 | 2033 | CAGR | |
---|---|---|---|---|
Global Heparin API Market Sales Revenue | 121212 | 121212 | 121212 | 4.75% |
Base Year | 2024 |
Historical Data Time Period | 2021-2024 |
Forecast Period | 2025-2033 |
Market Split by Type |
|
Market Split by Source |
|
Market Split by Product |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Report scope is customizable as we have a huge database of Heparin API industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Heparin API Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Heparin is an anticoagulant (blood thinner) that inhibits the development of blood clots. Heparin API is the most often utilized anticoagulant in a variety of medical treatments. It is critical in the management and prevention of blood clots during surgical and medical procedures.
Heparin is available as an intravenous (into a vein) or deep under the skin injection solution, as well as a dilute solution for injection into intravenous catheters. Heparin is occasionally injected one to six times each day, and it is sometimes administered slowly and continuously into the vein. Heparin is often used to prevent blood clots from developing in intravenous catheters when the catheter is first placed and every time blood is collected from the catheter or medicine is administered through the catheter.
Heparin API is often made from animal and bovine sources and comes in three forms: unfractionated heparin, low molecular weight heparins, and ultra-low molecular weight heparin (ULMWH). There are now various heparin products on the market, including Heparin Sodium API, Heparin Calcium API, and many more.
Currently, the rising prevalence of the blood-related disorder, cardiovascular diseases, and a growing number of surgical procedures are rising the demand for heparin API.
The lifestyle of people has been completely changed. A sedentary lifestyle, unhealthy diet, and lack of physical activity are among the common factors seen among the population. All these factors give birth to medical conditions including obesity or overweight, diabetes, high blood pressure, and high blood cholesterol among others. The increasing trend of smoking, tobacco, and alcohol are the cherries on the cake. All these factors are considered potential risk factors for the generation of acute coronary syndrome where the blood supplied to the heart cells/muscle is suddenly slowed or blocked due to the formation of a clot.
Cardiovascular diseases are on top of the list when it comes to causes of death and disability globally. The data from WHO has estimated that 17.9 million people died from CVDs in 2019, which accounts for 32% of all global deaths of which 85% of death accounts from heart attack and stroke. Estimated data shows that over one million babies globally are born with congenital heart defects (CHD)per year, of which more than 70% of congenital heart defects cases require medical or surgical care.
Further, around 34 million people globally suffer from rheumatic heart disease of which most of them can be benefited from surgical treatment. Heparin is considered a blood thinning medication that tends to prevent blood clot formation. Hence act as a potential element to prevent blot clots to prevent heart-associated risk. Moreover, heparin is also been used in heart surgery to prevent blood clots formation during surgery of the large arteries.
Hence, the increasing prevalence of cardiovascular diseases drives the growth of the Heparin API market.
We have various report editions of Heparin API Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Aspen Oss specializes in developing and manufacturing of steroid hormone APIs and other complex HPAPIs. It distributes its products across the world. The product portfolio of the company includes,
• High potency & oncology APIs
• Peptides
• Narcotics & analgesic APIs
• Botanical extraction APIs
• Biochemical APIs
Bioiberica S.A.U. is Spain based company. The company has more than 100 products that improve human, animal and plant health and operate in more than 80 countries. The company has following business units: heparin science, healthcare, companion animal health, animal nutrition and plant health. Further, the products of the company are segmented into human health, animal health and plant health.
Heparin science includes products such as heparin calcium, heparinoids heparin sodium, heparin lithium and others. Healthcare segment includes active pharmaceutical ingredients and branded ingredients.
March 2022
Bioiberica, a Life Science company specializing in the identification and extraction of biomolecules of therapeutic value for the nutraceutical and pharmaceutical industries, has partnered with ByHealth
Top Companies Market Share in Heparin API Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
Region and country analysis section of Heparin API Industry Analysis has been segmented into 5 major region such as North America, Europe, Asia Pacific, Middle East & Africa ,and Latin America (along with respective major contributing countries) and provides the revenue share, current trends.
The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of Heparin API market.
The current report Scope analyzes Heparin API Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Global Heparin API Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Heparin API Industry growth. Heparin API market has been segmented with the help of its Type, Source Product, and others. Heparin API market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
Unfractionated heparin (UFH) is a quick-acting blood thinner that interacts with antithrombin, a naturally occurring protein in the body, to prevent clot formation. Unfractionated heparin binds to antithrombin and increases its capacity to block two of the body's most powerful clotting factors, factor Xa and factor IIa, generally within minutes.
Low molecular weight heparin is an anticoagulant medication used to treat blood clots in the legs and other areas of the body. Heparin with a low molecular weight is given subcutaneously or intravenously. It is used to treat venous thromboembolism and to avoid blood clots (deep vein thrombosis and pulmonary embolism). Heparin with a low molecular weight is also used to treat myocardial infarction.
Ultralow molecular weight (ULMW) heparins are sulfated glycans utilized in the treatment of thrombotic diseases. The daltons of ULMW heparins range from 1500 to 3000, equating to 5 to 10 saccharide units. Arixtra (fondaparinux sodium) is a marketed medicine that is a structurally homogenous ULMW heparin pentasaccharide manufactured by a complex chemical process.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Heparin API Industry. Request a Free Sample PDF!
Traditionally, heparin was derived from pig intestines. Furthermore, pharmaceutical-grade heparin is taken from animals such as turkeys, mice, camels, whales, lobsters, freshwater mussels, clams, shrimps, and mangrove crabs. Heparin is secreted by granules found in mast cells.
The bovine-sourced heparin is produced using cow lungs. It is used for the mass-production as raw material. Notably, the pharmacological product bovine mucosa heparin is already marketed and produced in South America (e.g., Brazil and Argentina). Due to worries about the probable introduction of transmissible spongiform encephalopathy agents, manufacturers voluntarily removed bovine lung heparin from the US market in the late 1990s and replaced it with pig heparin. In 2008, certain swine heparin samples were discovered to be tainted with Over-Sulfated Chondroitin Sulfate (OSCS). Since then, the FDA has worked tirelessly to protect heparin products and related heparin supply networks. All potential manufacturers and suppliers of bovine heparin are encouraged by the FDA.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Heparin Sodium API is a sterile injection-ready formulation of heparin sodium generated from swine intestinal tissue that has been standardized for anticoagulant action. It is meant to be administered intravenously or deep subcutaneously. A biological analysis utilizing a USP reference standard based on units of heparin activity per milligram is used to measure potency.
Heparin calcium is the calcium salt of heparin, a negatively charged linear polysaccharide from the glycosaminoglycan family. The inclusion of a sequence of five sugars in the polysaccharide chain that can interact with the antithrombotic III (ATIII), speeding up the rate at which this protein blocks the blood's procoagulant factors, is its key property.
Several other products such as Heparin ammonium API and Heparin Lithium API are also available in the market. Ammonium heparin is notably recommended as an alternative to sodium heparin for measuring blood salt levels without interference. Lithium heparin is the most often advised kind of heparin due to its minimal impact with testing for other ions.
Research Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the medical devices & consumables industry. She has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services. Her expertise in Market Research and business intelligence has equipped her with the skills necessary to analyze complex information and provide strategic recommendations.
In her current role, Anushka is a highly motivated and detail-oriented research analyst with a passion for uncovering valuable insights from data. She thrives in dynamic environments where her analytical abilities and research expertise can contribute to informed decision-making for businesses. Her collaborative approach facilitated effective communication of insights, fostering a data-driven culture within the organization.Anushka remains an invaluable asset in the dynamic landscape of market research.
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Disclaimer:
Type | Unfractionated Heparin, Low Molecular Weight Heparins, Ultra-low Molecular Weight Heparin |
Source | Animal Sourced Heparin, Bovine Sourced Heparin |
Product | Heparin Sodium API, Heparin Calcium API, Others |
List of Competitors | Hepalink, Changshan Pharm, Qianhong Bio pharma, Opocrin, Pfizer, Aspen Oss, King friend Biochemical Pharmaceutical, Bioib rica, Dongcheng Biochemicals, Jiulong Biochemicals, Tiandong, Xinbai, Yino Pharma Limited, Deebio |
This chapter will help you gain GLOBAL Market Analysis of Heparin API. Further deep in this chapter, you will be able to review Global Heparin API Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Heparin API. Further deep in this chapter, you will be able to review North America Heparin API Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Heparin API. Further deep in this chapter, you will be able to review Europe Heparin API Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Heparin API. Further deep in this chapter, you will be able to review Asia Pacific Heparin API Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Heparin API. Further deep in this chapter, you will be able to review South America Heparin API Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Heparin API. Further deep in this chapter, you will be able to review Middle East Heparin API Market Split by various segments and Country Split.
Chapter 6 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Heparin API. Further deep in this chapter, you will be able to review Middle East Heparin API Market Split by various segments and Country Split.
Chapter 7 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Heparin API. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Type Analysis 2019 -2031, will provide market size split by Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Type Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Source Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Product Analysis 2021 - 2033
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Heparin API market
Chapter 13 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 14 Research Methodology and Sources
Why Unfractionated Heparin have a significant impact on Heparin API market? |
What are the key factors affecting the Unfractionated Heparin and Low Molecular Weight Heparins of Heparin API Market? |
What is the CAGR/Growth Rate of Animal Sourced Heparin during the forecast period? |
By type, which segment accounted for largest share of the global Heparin API Market? |
Which region is expected to dominate the global Heparin API Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|